These findings suggested that distinct cHA-based vaccination approaches resulted in differential cellular immune regulatory mechanisms, i.e., localized (draining lymph node) or systemic immunity, to correlate to the protection against pH1N1 virus infection. The gene discussed is TCFL5; the disease is viral infectious disease.